Pharma
Sun Pharmaceutical Industries Ltd
SUNPHARMA · NSE · INE044A01036Market Cap—
P/E—
P/B—
EPS—
Div Yield—
ROE14.8%
ROCE17.6%
ROE14.8%
1Y Return+4.66%
Avg. Volume1.7M
Price Chart
About
Sun Pharmaceutical Industries Ltd is a Pharma company listed on NSE.
Technicals
Free account
Register freeTechnicals
Create a free account to view momentum, moving averages, and delivery signals.
Quant
Premium
UpgradeQuant metrics
Upgrade to view volatility, drawdown, factor, and risk metrics.
Key Ratios
Market Cap—
Current Price—
52W High / Low—
Stock P/E—
Price to Book—
EPS (TTM)—
Dividend Yield—
ROE14.8%
1Y Return+4.66%
Day Change—
Profit & Loss
| Period | TTM | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | ₹59,911 Cr | ₹58,462 Cr | ₹52,578 Cr | ||||||||||
| Expenses | ₹42,063 Cr | ₹41,961 Cr | ₹37,464 Cr | ||||||||||
| Operating Profit | ₹17,847 Cr | ₹16,501 Cr | ₹15,114 Cr | ||||||||||
| OPM % | 30.0% | 28.0% | 29.0% | ||||||||||
| Other Income | ₹1,537 Cr | ₹1,895 Cr | ₹1,444 Cr | ||||||||||
| Depreciation | ₹2,976 Cr | ₹2,938 Cr | ₹2,575 Cr | ||||||||||
| Interest | ₹364 Cr | ₹339 Cr | ₹231 Cr | ||||||||||
| Profit Before Tax | ₹16,045 Cr | ₹15,119 Cr | ₹13,752 Cr | ||||||||||
| Tax | ₹3,928 Cr | ₹3,610 Cr | ₹2,787 Cr | ||||||||||
| Net Profit | ₹12,117 Cr | ₹11,509 Cr | ₹10,965 Cr | ||||||||||
| EPS (₹) | 50.4 | 47.8 | 45.6 | ||||||||||
| Dividend Payout % | — | 33% | 35% |
Financial history locked
Register freeRegister free to see 10 more years.
Quarterly Results
| Quarter | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | ₹15,300 Cr | ₹14,612 Cr | ₹15,521 Cr | ₹14,478 Cr | |||||||||
| Expenses | ₹10,882 Cr | ₹10,658 Cr | ₹10,572 Cr | ₹9,951 Cr | |||||||||
| Operating Profit | ₹4,418 Cr | ₹3,954 Cr | ₹4,948 Cr | ₹4,527 Cr | |||||||||
| OPM % | 29.0% | 27.0% | 32.0% | 31.0% | |||||||||
| Depreciation | ₹739 Cr | ₹775 Cr | ₹732 Cr | ₹730 Cr | |||||||||
| Interest | ₹100 Cr | ₹86 Cr | ₹78 Cr | ₹100 Cr | |||||||||
| Net Profit | ₹2,901 Cr | ₹2,710 Cr | ₹3,381 Cr | ₹3,125 Cr | |||||||||
| EPS (₹) | 12.1 | 11.3 | 14.0 | 13.0 |
Quarterly history locked
Register freeRegister free to see 9 more quarters.
Balance Sheet
| Period | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity Capital | ₹240 Cr | ₹240 Cr | ₹240 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reserves | ₹83,330 Cr | ₹71,978 Cr | ₹63,427 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Borrowings | ₹4,627 Cr | ₹2,362 Cr | ₹3,274 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Liabilities | ₹20,210 Cr | ₹17,328 Cr | ₹18,387 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Liabilities | ₹1,08,407 Cr | ₹91,908 Cr | ₹85,328 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fixed Assets | ₹32,822 Cr | ₹22,586 Cr | ₹23,248 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments | ₹24,723 Cr | ₹18,354 Cr | ₹15,026 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Receivables | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventory | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash & Equivalents | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Assets | ₹47,811 Cr | ₹44,324 Cr | ₹41,700 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Assets | ₹1,08,407 Cr | ₹91,908 Cr | ₹85,328 Cr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance sheet history locked
Register freeRegister free to see 10 more years.
Cash Flow
| Period | Operating | Investing | Financing | Net Cash Flow |
|---|---|---|---|---|
| FY26 | ₹12,419 Cr | ₹-10,405 Cr | ₹-2,513 Cr | ₹-498 Cr |
| FY25 | ₹14,072 Cr | ₹-5,183 Cr | ₹-7,906 Cr | ₹983 Cr |
| FY24 | ₹12,135 Cr | ₹-763 Cr | ₹-6,710 Cr | ₹4,662 Cr |
| FY23 | ||||
| FY22 | ||||
| FY21 | ||||
| FY20 | ||||
| FY19 | ||||
| FY18 | ||||
| FY17 | ||||
| FY16 | ||||
| FY15 |
Cash flow history locked
Register freeRegister free to see 10 more years.
Peer Comparison
| Company | M.Cap | P/E | ROE | 1Y Return |
|---|---|---|---|---|
| 3B BlackBio Dx Ltd | ₹1,210 Cr | 21.4 | +20.2% | +17.9% |
| Aarey Drugs & Pharmaceuticals Ltd | ₹353 Cr | 75.3 | +2.75% | +59.84% |
| Aarti Drugs Ltd | ₹3,429 Cr | 18.0 | +13.37% | +11.57% |
| Aarti Pharmalabs Ltd | ₹7,495 Cr | 35.2 | +8.51% | +14.26% |
| Abbott India Ltd | — | — | +34.46% | -7.16% |
Mutual Fund Holdings
Free account
Register freeMutual fund holdings
Create a free account to see institutional ownership snapshots.
Bulk & Block Deals
Free account
Register freeBulk & block deals
Create a free account to view recent institutional deal activity.
Analyst Estimates
Free account
Register freeAnalyst estimates
Create a free account to view analyst estimate summaries.
Latest News
2026-10-23Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE Filing2026-08-31Trump Strikes Medicaid Drug Price Deals With Nine Pharma FirmsBloomberg2026-08-19Active Pharmaceutical Ingredients (API) Market Report 2026-2036 Just Released — Analyses Synthetic, Biotech, Traditional and Highly Potent APIsGlobeNewswire2026-07-30Earnings To Watch: Sun Pharmaceuticals Industries Ltd (NSE:SUNPHARMA) Q1 2027 -- GF Value Sees ...GuruFocus.com
Documents & Filings
rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.